Deep learning-based analysis of EGFR mutation prevalence in lung adenocarcinoma H&E whole slide images.

Journal: The journal of pathology. Clinical research
Published Date:

Abstract

EGFR mutations are a major prognostic factor in lung adenocarcinoma. However, current detection methods require sufficient samples and are costly. Deep learning is promising for mutation prediction in histopathological image analysis but has limitations in that it does not sufficiently reflect tumor heterogeneity and lacks interpretability. In this study, we developed a deep learning model to predict the presence of EGFR mutations by analyzing histopathological patterns in whole slide images (WSIs). We also introduced the EGFR mutation prevalence (EMP) score, which quantifies EGFR prevalence in WSIs based on patch-level predictions, and evaluated its interpretability and utility. Our model estimates the probability of EGFR prevalence in each patch by partitioning the WSI based on multiple-instance learning and predicts the presence of EGFR mutations at the slide level. We utilized a patch-masking scheduler training strategy to enable the model to learn various histopathological patterns of EGFR. This study included 868 WSI samples from lung adenocarcinoma patients collected from three medical institutions: Hallym University Medical Center, Inha University Hospital, and Chungnam National University Hospital. For the test dataset, 197 WSIs were collected from Ajou University Medical Center to evaluate the presence of EGFR mutations. Our model demonstrated prediction performance with an area under the receiver operating characteristic curve of 0.7680 (0.7607-0.7720) and an area under the precision-recall curve of 0.8391 (0.8326-0.8430). The EMP score showed Spearman correlation coefficients of 0.4705 (p = 0.0087) for p.L858R and 0.5918 (p = 0.0037) for exon 19 deletions in 64 samples subjected to next-generation sequencing analysis. Additionally, high EMP scores were associated with papillary and acinar patterns (p = 0.0038 and p = 0.0255, respectively), whereas low EMP scores were associated with solid patterns (p = 0.0001). These results validate the reliability of our model and suggest that it can provide crucial information for rapid screening and treatment plans.

Authors

  • Jun Hyeong Park
    Department of Radiation Oncology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • June Hyuck Lim
    Department of Radiation Oncology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Seonhwa Kim
    Research Center, Software Division, NGeneBio, Seoul, 08390, Korea.
  • Chul-Ho Kim
    Department of Otolaryngology, Ajou University School of Medicine, 164 Worldcup-ro, Yeongtong-gu, Suwon, 16499, Republic of Korea. ostium@ajou.ac.kr.
  • Jeong-Seok Choi
    Department of Otorhinolaryngology-Head and Neck Surgery, Inha University College of Medicine, Incheon, Republic of Korea.
  • Jun Hyeok Lim
    Division of Pulmonology, Department of Internal Medicine, Inha University College of Medicine, Incheon, Republic of Korea.
  • Lucia Kim
    Department of Pathology, Inha University College of Medicine, Incheon, Republic of Korea.
  • Jae Won Chang
    Department of Otolaryngology-Head and Neck Surgery, Chungnam National University Hospital, Daejeon, Republic of Korea.
  • Dongil Park
    Division of Pulmonary, Allergy and Critical Care Medicine, Critical Care Medicine, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea.
  • Myung-Won Lee
    Department of Control and Instrumentation Engineering, Chosun University, 375 Seosuk-dong, Dong-gu, Gwangju 501-759, Republic of Korea.
  • Sup Kim
    Department of Radiation Oncology, Chungnam National University Hospital, Daejeon, Republic of Korea.
  • Il-Seok Park
    Department of Otorhinolaryngology-Head and Neck Surgery, Hallym University Dontan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Republic of Korea.
  • Seung Hoon Han
    Department of Otorhinolaryngology-Head and Neck Surgery, Hallym University Dontan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Republic of Korea.
  • Eun Shin
    Department of Pathology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Republic of Korea.
  • Jin Roh
    Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Jaesung Heo
    Department of Radiation Oncology, Ajou University School of Medicine, Suwon, Republic of Korea.